Cannabidiol Genetics

Cannabidiol (CBD) genetics refers to cannabis breeding lines selected or stabilized for elevated cannabidiol production relative to THC. These genetics are derived from both industrial hemp cultivars and specialized medical/recreational breeding programs that prioritize CBD accumulation through selective breeding and backcrossing. CBD-dominant strains often carry recessive or suppressed THC-synthesis traits, allowing cannabidiol to accumulate as the primary cannabinoid. Lineage records frequently report CBD genetics originating from landraces like Harle-Tsu, Charlotte's Web, and Cannatonic, which breeders have maintained and crossed to develop modern CBD-forward cultivars. The CBD:THC ratio varies widely—from roughly 1:1 balanced strains to heavily CBD-dominant lines exceeding 20:1 ratios. Understanding CBD genetics is essential for seed selection, breeding strategy, and consistent canna

Breeders working in CBD genetics use parent-plant cannabinoid testing (HPLC/GC-MS) to identify and stabilize CBD-expressing lines. CBD-dominant genetics serve as crucial foundation stock for developing balanced hybrids, CBD-rich F1 crosses, and preservation of chemically distinct cultivar families.